330216-62-1 Usage
Description
METHYL 2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE is a complex chemical compound that is a derivative of pyridine. It features a methyl ester group, a trifluoromethylphenyl group, and a carboxylate group, which contribute to its potential applications in various fields.
Uses
Used in Organic Synthesis:
METHYL 2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE is used as a building block in organic synthesis for the creation of new compounds and materials.
Used in Pharmaceutical Research:
In the pharmaceutical industry, METHYL 2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE is used as a precursor in the development of new drugs and pharmaceuticals, owing to its unique molecular structure.
Used in Pesticide Production:
METHYL 2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE is used as a chemical intermediate in the production of pesticides, contributing to the development of effective agrochemicals.
Used in Agrochemical Production:
Similarly, in the agrochemical sector, METHYL 2-METHYL-6-OXO-4-[4-(TRIFLUOROMETHYL)PHENYL]-1,4,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLATE serves as a key component in formulating new products designed to protect crops and enhance agricultural yields.
Check Digit Verification of cas no
The CAS Registry Mumber 330216-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,0,2,1 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 330216-62:
(8*3)+(7*3)+(6*0)+(5*2)+(4*1)+(3*6)+(2*6)+(1*2)=91
91 % 10 = 1
So 330216-62-1 is a valid CAS Registry Number.
330216-62-1Relevant articles and documents
Development of dihydropyridone indazole amides as selective rho-kinase inhibitors
Goodman, Krista B.,Cui, Haifeng,Dowdell, Sarah E.,Gaitanopoulos, Dimitri E.,Ivy, Robert L.,Sehon, Clark A.,Stavenger, Robert A.,Wang, Gren Z.,Viet, Andrew Q.,Xu, Weiwei,Ye, Guosen,Semus, Simon F.,Evans, Christopher,Fries, Harvey E.,Jolivette, Larry J.,Kirkpatrick, Robert B.,Dul, Edward,Khandekar, Sanjay S.,Yi, Tracey,Jung, David K.,Wright, Lois L.,Smith, Gary K.,Behm, David J.,Bentley, Ross,Doe, Christopher P.,Hu, Erding,Lee, Dennis
, p. 6 - 9 (2007/10/03)
Rho kinase (ROCK1) mediates vascular smooth muscle contraction and is a potential target for the treatment of hypertension and related disorders. Indazole amide 3 was identified as a potent and selective ROCK1 inhibitor but possessed poor oral bioavailabi
